Unravelling transplant-ineligible newly diagnosed multiple myeloma treatment in real-world practice in Spain: CARINAE study

被引：0
|
作者：
Casanova Espinosa, Maria [1 ]
Hernandez Garcia, Miguel Teodoro [2 ]
Soler Campos, Juan Alfons [3 ]
Herraez Rodriguez, Susana [4 ]
Moreno Belmonte, Maria Jose [5 ]
Gonzalez-Pardo, Miriam [6 ]
Gironella Mesa, Mercedes [7 ]
de Arriba de la Fuente, Felipe [8 ]
机构：
[1] Hosp Costa Sol, Marbella, Malaga, Spain
[2] Hosp Univ Canarias, Santa Cruz De Tenerife, Spain
[3] Consorci Corp Sanitaria Parc Tauli Sabadell, Cataluna, Spain
[4] Hosp Univ Basurto, Bizcaia, Spain
[5] Hosp Clin Univ Virgen de la Arrixaca, Murcia, Spain
[6] Janssen Cilag SA Spain, Madrid, Spain
[7] Hosp Univ Vall dHebron, Barcelona, Spain
[8] Hosp Gen Univ Morales Meseguer, Murcia, Spain
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-108
引用
收藏
页码：S93 / S94
页数：2
相关论文
共 50 条
  • [1] Unravelling Transplant-Ineligible Newly Diagnosed Multiple Myeloma Treatment in Real-World Practice in Spain. Carinae Study
    Casanova Espinosa, Maria
    Hernandez Garcia, Miguel Teodoro
    Soler Campos, Juan Alfonso
    Hernandez Rodriguez, Susana
    Moreno Belmonte, Maria Jose
    Gonzalez Pardo, Miriam Concepcion
    Gironella Mesa, Mercedes
    de Arriba de la Fuente, Felipe
    [J]. BLOOD, 2023, 142
  • [2] A glimpse into transplant-ineligible newly diagnosed multiple myeloma treatment in real-world practice in Spain: carinae study
    de Arriba de la Fuente, Felipe
    Hernandez Garcia, Miguel Teodoro
    Soler Campos, Juan Alfons
    Herraez Rodriguez, Susana
    Jose Moreno, Ma
    Conzalez Pardo, Miriam
    Gironella Mesa, Mercedes
    Casanova Espinosa, Maria
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S143 - S144
  • [3] Treatment patterns and outcomes in real-world transplant-ineligible patients newly diagnosed with multiple myeloma
    Cejalvo, Maria Jose
    Bustamante, Gabriela
    Gonzalez, Esther
    Vazquez-Alvarez, Judith
    Garcia, Ricarda
    Ramirez-Payer, Angel
    Perez-Persona, Ernesto
    Abella, Eugenia
    Garzon, Sebastian
    Garcia, Antoni
    Jarque, Isidro
    Gonzalez, Marta Sonia
    Sampol, Antonia
    Motllo, Cristina
    Marti, Josep Maria
    Alcala, Magdalena
    Duro, Rafael
    Gonzalez, Yolanda
    Sastre, Jose Luis
    Sarra, Josep
    Lostaunau, Giselle
    Lopez, Rocio
    de la Rubia, Javier
    [J]. ANNALS OF HEMATOLOGY, 2021, 100 (07) : 1769 - 1778
  • [4] Treatment patterns and outcomes in real-world transplant-ineligible patients newly diagnosed with multiple myeloma
    María José Cejalvo
    Gabriela Bustamante
    Esther González
    Judith Vázquez-Álvarez
    Ricarda García
    Ángel Ramírez-Payer
    Ernesto Pérez-Persona
    Eugenia Abella
    Sebastián Garzón
    Antoni García
    Isidro Jarque
    Marta Sonia González
    Antonia Sampol
    Cristina Motlló
    Josep María Martí
    Magdalena Alcalá
    Rafael Duro
    Yolanda González
    José Luis Sastre
    Josep Sarrà
    Giselle Lostaunau
    Rocío López
    Javier de la Rubia
    [J]. Annals of Hematology, 2021, 100 : 1769 - 1778
  • [5] Quadruplets in newly diagnosed transplant-ineligible multiple myeloma
    Chakraborty, Rajshekhar
    Mian, Hira
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2024,
  • [6] Dose intensity and treatment duration of bortezomib in transplant-ineligible newly diagnosed multiple myeloma
    Ibarra, Gladys
    Pena, Marta
    Abril, Laura
    Senin, Alicia
    Maluquer, Clara
    Clapes, Victoria
    Baca, Cristina
    Bustamante, Gabriela
    Sureda, Anna
    Oriol, Albert
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 107 (02) : 246 - 254
  • [7] Practice Patterns in Front-line Treatment of Transplant-Eligible and Transplant-Ineligible Newly Diagnosed Multiple Myeloma
    Poy, Theprungsirikul
    Liu Yuxin
    Natalia, Neparidze
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : S28 - S28
  • [8] Real-World Outcomes in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma Treated With Bortezomib/Cyclophosphamide/Dexamethasone and Bortezomib/Lenalidomide/Dexamethasone as Upfront Treatment
    Saeed, Nabiha
    Khan, Zurrya
    Jehanzeb, Hamzah
    Shaikh, Taha
    Shaikh, Usman
    Adil, Salman N.
    Madni, Varisha
    Fatima, Hania
    Abiha, Umm E.
    Ali, Natasha
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [9] Efficacy and tolerability of VCD chemotherapy in a UK real-world dataset of elderly transplant-ineligible newly diagnosed myeloma patients
    Rampotas, Alexandros
    Djebbari, Faouzi
    Panitsas, Fotios
    Lees, Charlotte
    Tsagkaraki, Ismini
    Gomes, Ana Rita
    Prideaux, Steve
    Chen, Lucia
    Prodger, Catherine
    Khera, Akhil
    Gray, Nicola
    Ellis, Lauren
    Sangha, Gavinda
    Lim, Wen Yuen
    Eyre, Toby A.
    Moore, Sally
    Ramasamy, Karthik
    Kothari, Jaimal
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (04) : 563 - 573
  • [10] Daratumumab: A Review in Combination Therapy for Transplant-Ineligible Newly Diagnosed Multiple Myeloma
    Yahiya Y. Syed
    [J]. Drugs, 2019, 79 : 447 - 454
12345